On Thursday, the Food and Drug Administration’s (FDA) committee on compounded drugs broke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies can make, despite concerns being raised over the lack of demonstrated benefits. The FDA’s Pharmacy Compounding Advisory Committee (PCAC) heard public comments and saw presentations by agency staffers concerning the peptides BPC-157, KPV, TB-500 and MOTS-c. These…
Single-Cell Atlas Simultaneously Maps 3D Genome Architecture and DNA Methylation
Scientists at the Salk Institute and the Arc Institute, along with their collaborators, unveiled the first body-wide single-cell atlas of two major epigenetic systems: three-dimensional
